1-Alpha, 25-dihydroxy vitamin D3 inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression. (Q46008001)

18 December 2017

title

1-Alpha, 25-dihydroxy vitamin D3 inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression. (English)

1 reference

18 December 2017

1 reference

Sadaoki Sakai

1

1 reference

18 December 2017

Hironari Takaishi

2

1 reference

18 December 2017

Kenichiro Matsuzaki

3

1 reference

18 December 2017

Hironori Kaneko

4

1 reference

18 December 2017

Mitsuru Furukawa

5

1 reference

18 December 2017

Yoshiteru Miyauchi

6

1 reference

18 December 2017

Ayako Shiraishi

7

1 reference

18 December 2017

Keiji Saito

8

1 reference

18 December 2017

Akio Tanaka

9

1 reference

18 December 2017

Tadatsugu Taniguchi

10

1 reference

18 December 2017

Toshio Suda

11

1 reference

18 December 2017

Takeshi Miyamoto

12

1 reference

18 December 2017

Yoshiaki Toyama

13

1 reference

18 December 2017

publication date

19 May 2009

1 reference

18 December 2017

Journal of Bone and Mineral Metabolism

published in

1 reference

18 December 2017

volume

27

1 reference

18 December 2017

issue

6

1 reference

18 December 2017

page(s)

643-652

1 reference

18 December 2017

ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00774-009-0084-4

Reactive oxygen species induce chondrocyte hypertrophy in endochondral ossification.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00774-009-0084-4

Dimer formation of receptor activator of nuclear factor kappaB induces incomplete osteoclast formation.

21 January 2018

1 reference

12 December 2020

Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts

1 reference

12 December 2020

Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos

1 reference

12 December 2020

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

1 reference

12 December 2020

Calcitriol in the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Sequences in the human parathyroid hormone gene that bind the 1,25-dihydroxyvitamin D3 receptor and mediate transcriptional repression in response to 1,25-dihydroxyvitamin D3

1 reference

12 December 2020

Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets.

1 reference

12 December 2020

Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium

1 reference

12 December 2020

NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF.

1 reference

12 December 2020

A new active vitamin D, ED-71, increases bone mass in osteoporotic patients under vitamin D supplementation: a randomized, double-blind, placebo-controlled clinical trial

1 reference

12 December 2020

Pleiotropic effects of a null mutation in the c-fos proto-oncogene

1 reference

12 December 2020

Bifurcation of osteoclasts and dendritic cells from common progenitors

1 reference

12 December 2020

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

12 December 2020

5'-flanking region of the parathyroid hormone gene mediates negative regulation by 1,25-(OH)2 vitamin D3.

1 reference

12 December 2020

Osteoclast-like cells form in long-term human bone marrow but not in peripheral blood cultures

1 reference

12 December 2020

Differentiation and function of osteoclasts

1 reference

12 December 2020

RANK is essential for osteoclast and lymph node development

1 reference

12 December 2020

Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice

1 reference

12 December 2020

c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs

1 reference

12 December 2020

Sustained osteoblast nuclear receptor binding of converted 1alpha, 25-dihydroxyvitamin D3 after administration of 3H-1alpha-hydroxyvitamin D3: a combined receptor autoradiography and radioassay time course study with comparison to 3H-1alpha, 25-dihy

1 reference

12 December 2020

Bone mass and markers of bone and calcium metabolism in postmenopausal women treated with 1,25-dihydroxyvitamin D (Calcitriol) for four years

1 reference

12 December 2020

Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen

1 reference

12 December 2020

DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells

1 reference

12 December 2020

Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation

1 reference

12 December 2020

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

1 reference

12 December 2020

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients

1 reference

12 December 2020

RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β

1 reference

12 December 2020

Autoamplification of NFATc1 expression determines its essential role in bone homeostasis

1 reference

12 December 2020

10.1007/S00774-009-0084-4

Identifiers

DOI

1 reference

18 December 2017

1 reference

18 December 2017